BASF invests in Chinese synbio start-up
The chemical company BASF is counting on synthetic biology for industrial production and is investing in the Chinese start-up Bota Biosciences Ltd. (Bota Bio) through its in-house venture capital company BASF Venture Capital GmbH. The amount of the investment was not disclosed. Founded in 2019, the Hangzhou-based company relies on a platform that combines IT, biotechnology and automation. With the help of the technology, microorganisms for the production of various products can be quickly identified, characterised and reprogrammed.